Ruben S A Goedegebuure
Overview
Explore the profile of Ruben S A Goedegebuure including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Groen-van Schooten T, Harrasser M, Seidel J, Bos E, Fleitas T, van Mourik M, et al.
Front Immunol
. 2024 Apr;
15:1372272.
PMID: 38638445
Background: Tumors in the distal esophagus (EAC), gastro-esophageal junction including cardia (GEJAC), and stomach (GAC) develop in close proximity and show strong similarities on a molecular and cellular level. However,...
2.
Goedegebuure R, Kleibeuker E, Buffa F, Castricum K, Haider S, Schulkens I, et al.
J Exp Clin Cancer Res
. 2021 May;
40(1):161.
PMID: 33964942
Background: Improvement of radiotherapy efficacy requires better insight in the dynamic responses that occur during irradiation. Here, we aimed to identify the molecular responses that are triggered during clinically applied...
3.
de Klerk L, Goedegebuure R, van Grieken N, van Sandick J, Cats A, Stiekema J, et al.
Mol Oncol
. 2021 Jan;
15(4):901-914.
PMID: 33506581
Identification of molecular predictive markers of response to neoadjuvant chemoradiation could aid clinical decision-making in patients with localized oesophageal cancer. Therefore, we subjected pretreatment biopsies of 75 adenocarcinoma (OAC) and...
4.
Goedegebuure R, Wentink M, van der Vliet H, Timmerman P, Griffioen A, de Gruijl T, et al.
Oncologist
. 2020 Oct;
26(2):e218-e229.
PMID: 33105058
Lessons Learned: The novel therapeutic vaccine hVEGF /RFASE was found to be safe and well tolerated in patients with cancer. hVEGF /RFASE failed to induce seroconversion against native hVEGF and,...
5.
van den Berg J, Castricum K, Meel M, Goedegebuure R, Lagerwaard F, Slotman B, et al.
Radiother Oncol
. 2020 Apr;
148:107-114.
PMID: 32344261
Background And Purpose: Effective combination treatments with fractionated radiotherapy rely on a proper understanding of the dynamic responses that occur during treatment. We explored the effect of clinical fractionated radiotherapy...
6.
Goedegebuure R, Vonk C, Kooij L, Derks S, Thijssen V
Int J Radiat Oncol Biol Phys
. 2020 Feb;
108(1):56-69.
PMID: 32068114
Radiation therapy has been linked to the induction of an intratumoral type I interferon (IFN) response, which positively affects the response to treatment. This has spiked the interest to combine...
7.
Voeten D, den Bakker C, Goedegebuure R, Heineman D, Daams F, van der Peet D
Ned Tijdschr Geneeskd
. 2019 Sep;
163.
PMID: 31556490
The incidence of oesophageal cancer is on the rise, particularly due to an increase in the number of adenocarcinomas of the distal oesophagus. Adenomas and squamous cell carcinomas are the...
8.
Goedegebuure R, de Klerk L, Bass A, Derks S, Thijssen V
Front Immunol
. 2019 Jan;
9:3107.
PMID: 30692993
Radiotherapy has been used for the treatment of cancer for over a century. Throughout this period, the therapeutic benefit of radiotherapy has continuously progressed due to technical developments and increased...
9.
Janse J, Goedegebuure R, Veersema S, Broekmans F, Schreuder H
J Minim Invasive Gynecol
. 2013 Jun;
20(6):775-82.
PMID: 23806561
Study Objective: To assess the learning curve using a virtual reality simulator for hysteroscopic sterilization with the Essure method. Design: Prospective multicenter study (Canadian Task Force classification II-2). Setting: University...